van der Woude F - Search Results

1

Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression.

Allmaras E, Nowack R, Andrassy K, Waldherr R, van der Woude F, Ritz E. Allmaras E, et al. Among authors: van der woude f. Clin Nephrol. 1997 Nov;48(5):269-73. Clin Nephrol. 1997. PMID: 9403209

2

IgA nephropathy and hodgkin's disease: a rare coincidence. Case report and literature review.

Bergmann J, Buchheidt D, Waldherr R, Maywald O, van der Woude FJ, Hehlmann R, Braun C. Bergmann J, et al. Am J Kidney Dis. 2005 Jan;45(1):e16-9. doi: 10.1053/j.ajkd.2004.09.007. Am J Kidney Dis. 2005. PMID: 15696435

3

Upregulation of CD14 and CD18 on monocytes In vitro by antineutrophil cytoplasmic autoantibodies.

Nowack R, Schwalbe K, Flores-Suárez LF, Yard B, VAN DER Woude FJ. Nowack R, et al. J Am Soc Nephrol. 2000 Sep;11(9):1639-1646. doi: 10.1681/ASN.V1191639. J Am Soc Nephrol. 2000. PMID: 10966488

4

15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.

Birck R, Warnatz K, Lorenz HM, Choi M, Haubitz M, Grünke M, Peter HH, Kalden JR, Göbel U, Drexler JM, Hotta O, Nowack R, Van Der Woude FJ. Birck R, et al. J Am Soc Nephrol. 2003 Feb;14(2):440-7. doi: 10.1097/01.asn.0000048716.42876.14. J Am Soc Nephrol. 2003. PMID: 12538745

5

Renal granulomas in systemic vasculitis. EC/BCR Project for ANCA-Assay Standardization.

Bajema IM, Hagen EC, Ferrario F, Waldherr R, Noël LH, Hermans J, van der Woude FJ, Bruijn JA. Bajema IM, et al. Among authors: van der woude fj. Clin Nephrol. 1997 Jul;48(1):16-21. Clin Nephrol. 1997. PMID: 9247773

6

Severe renal arterio-arteriolosclerosis after cocaine use.

van der Woude FJ, Waldherr R. van der Woude FJ, et al. Nephrol Dial Transplant. 1999 Feb;14(2):434-5. doi: 10.1093/ndt/14.2.434. Nephrol Dial Transplant. 1999. PMID: 10069205 No abstract available.

7

Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement.

Nowack R, Göbel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ. Nowack R, et al. Among authors: van der woude fj. J Am Soc Nephrol. 1999 Sep;10(9):1965-71. doi: 10.1681/ASN.V1091965. J Am Soc Nephrol. 1999. PMID: 10477149

8

Immunosuppression in ANCA-associated vasculitis.

van der Woude FJ, Schmitt WH, Birck R, Nowack R, Göbel U, Drexler JM, Hotta O. van der Woude FJ, et al. Transplant Proc. 2001 May;33(3):2225-6. doi: 10.1016/s0041-1345(01)01948-0. Transplant Proc. 2001. PMID: 11377509 No abstract available.

9

ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.

Nowack R, Grab I, Flores-Suarèz LF, Schnülle P, Yard B, van der Woude FJ. Nowack R, et al. Among authors: van der woude fj. Nephrol Dial Transplant. 2001 Aug;16(8):1631-7. doi: 10.1093/ndt/16.8.1631. Nephrol Dial Transplant. 2001. PMID: 11477166

10

Treatment of immunoglobulin A nephropathy.

Schiele J, Nowack R, Julian BA, van der Woude FJ. Schiele J, et al. Among authors: van der woude fj. Ann Med Interne (Paris). 1999 Feb;150(2):127-36. Ann Med Interne (Paris). 1999. PMID: 10392261 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters